Dare Bioscience DARE
NASDAQ DARE
$0.69 +0.00 (+0.29%)
At close: Nov 11, 2026 · 4:00 PM EST

Dare Bioscience (DARE) Gross Profit (2025 - 2026)

Updated

Dare Bioscience (DARE) posted Gross Profit of -$132,343 for Q2 2026, compared with -$21,172 a year earlier.

Analysis

Dare Bioscience (DARE) Gross Profit (2025 - 2026) Analysis & Trends

For FY2025, Dare Bioscience's Gross Profit came in at $734,394.

  • In prior years, Dare Bioscience's Gross Profit was $9,784 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Dare Bioscience 10.47 Mn -68.48 Mn -132,343.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -132,343.00
Mar 31, 2026 -89,870.00
Jun 30, 2025 21,172.00
Mar 31, 2025 25,427.00
API Access

Dare Bioscience Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=DARE&period=max&api_key=YOUR_API_KEY